Stocks gain, yields lower after Fed signals possible rate cuts
By Lewis Krauskopf NEW YORK (Reuters) - A gauge of global stock markets added to gains on Wednesday and benchmark U.S. Treasury yields and the U.S
By Lewis Krauskopf
NEW YORK (Reuters) - A gauge of global stock markets added to gains on Wednesday and benchmark U.S. Treasury yields and the U.S. dollar fell after the U.S. Federal Reserve signaled possible rate cuts of as much as half a percentage point over the remainder of this year.
The U.S. central bank held interest rates steady and said it "will act as appropriate to sustain" the economic expansion as it approaches the 10-year mark and dropped a promise to be "patient" in adjusting rates.
The market expects the Fed could cut rates as soon as next month.
"I think it’s right in line with market expectations, puts a July cut in play,” said Brett Ewing, chief market strategist at First Franklin Financial Services in Tallahassee, Florida.
Investors' hopes that the Fed would soon cut interest rates had been fueled on Tuesday when European Central Bank President Mario Draghi hinted at economic stimulus, comments that drove up stocks and weakened yields.
"We think the Fed delivered," said John Augustine, chief investment officer at Huntington National Bank in Columbus, Ohio. "It did no harm. It walked right up to a cut without doing it today. It'll likely be coming in July, absent some big trade news or other news."
MSCI's gauge of stocks across the globe gained 0.66%.
On Wall Street, the Dow Jones Industrial Average rose 50.53 points, or 0.19%, to 26,516.07, the S&P 500 gained 5.91 points, or 0.20%, to 2,923.66 and the Nasdaq Composite added 8.02 points, or 0.1%, to 7,961.91.
The pan-European STOXX 600 index was little changed.
Benchmark 10-year U.S. notes last rose 5/32 in price to yield 2.0422%, from 2.058% late on Tuesday.
The dollar index, which measures the greenback against a basket of currencies, fell 0.54%, with the euro up 0.51% to $1.1248.
U.S. crude fell 0.22% to $53.78 per barrel and Brent was last at $61.82, down 0.51% on the day.
(Additional reporting by Sinéad Carew, Gertrude Chavez-Dreyfuss in New York and Sujata Rao in London; Editing by Hugh Lawson, Jonathan Oatis and Lisa Shumaker)
This story has not been edited by Firstpost staff and is generated by auto-feed.
Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.
(Reuters) - Gilead Sciences Inc is nearing a deal to buy biopharmaceutical company Immunomedics Inc for more than $20 billion, the Wall Street Journal reported on Saturday, citing people familiar with the matter. A deal for Immunomedics, which last month reported positive data from a late-stage study for its breast-cancer drug, could be announced Monday if not sooner, the Journal said https://www.wsj.com/articles/gilead-nears-deal-to-buy-immunomedics-for-more-than-20-billion-11599936777?mod=hp_lead_pos2. Gilead and Immunomedics did not respond immediately to emailed requests from Reuters for comment
SHANGHAI (Reuters) - China banned pork imports from Germany on Saturday after it confirmed its first case of African swine fever last week, in a move set to hit German producers and push up global prices as China's meat supplies tighten. China's ban on imports from its third largest supplier comes as the world's top meat buyer deals with an unprecedented pork shortage after its own epidemic of the deadly hog disease. The ban on Germany, which has supplied about 14% of China's pork imports so far this year, will push up demand for meat from other major suppliers like the United States and Spain, boosting global prices.
CAIRO (Reuters) - Libyan commander Khalifa Haftar has committed to ending a months-long blockade of oil facilities, the U.S.